The Patent Finder

Terms ending in 2031

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,968,746Complexation of Nucleic Acids with Disulfide-Crosslinked Cationic Components for Transfection and Immunostimulation
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 9,234,013Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 9,839,697Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,010,592Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Tumour Antigen
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,232,024Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Allergenic Antigen or an Autoimmune Self-Antigen
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 10,653,799Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 11,110,156Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Tumour Antigen
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,109,275Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(A) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
In force
 · Medium confidence
Curevac SEIn forceMedium confidence
US 9,226,959Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant
In force
 · High confidence
Curevac SEIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited